Skip to content

Elution Solution (K812565)

by Biological Corp. of America

510(k) K812565

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK812565 Date23 Oct 1981ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Elution Solution
510(k) Number
FDA Product Code
KSG
Device Class
Class II
Regulation
21 CFR Part 864.9600
Advisory Committee
Hematology
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Elution Solution is a Media, Potentiating for In Vitro Diagnostic Use, designed to remove residual antibodies from preceding detection layers in sequential multiplex immunohistochemistry. This process prevents crosstalk between sequential staining layers, thereby ensuring specificity and accuracy in diagnostic testing. Its primary function is to facilitate clear and reliable antibody detection in hematological assays.

This solution is supplied as a sterile, single-use reagent intended for laboratory use in in vitro diagnostic procedures. It is classified under FDA device class II and was granted FDA 510(k) clearance (K812565) under the Hematology advisory committee. No third-party involvement is noted, and it adheres to regulatory requirements outlined in 21 CFR 864.9600. Storage and handling conditions are not specified but must comply with standard laboratory practices for sterile reagents.

Other devices from Bca Biological Corp. of America

  • Freeze Dried Papain

    Class II
  • Em-V

    Class II
  • Hematology Control

    Class II
  • Freeze Dried Ficin

    Class II
  • Em-X

    Class II
  • Recap

    Class II

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Biological Elution Solution used for in laboratory diagnostics?

    The Biological Elution Solution is designed specifically for in vitro diagnostic use in sequential multiplex immunohistochemistry. Its primary purpose is to remove residual antibodies from preceding detection layers, thereby preventing crosstalk between sequential staining steps. This ensures specificity and accuracy in detecting antibodies during hematological assays, particularly in complex diagnostic workflows where multiple markers are analyzed.

  • How is the Biological Elution Solution supplied and intended for use?

    The solution is supplied as a sterile, single-use reagent, meaning each vial is intended for one-time use in laboratory settings. This format minimizes contamination risks and ensures consistency in diagnostic testing. It adheres to standard laboratory practices for sterile reagents, though specific storage conditions are not detailed beyond general regulatory compliance.

  • Is the Biological Elution Solution reusable or meant for single-use only?

    The Biological Elution Solution is explicitly labeled as a single-use reagent. Single-use design reduces the risk of cross-contamination between samples and maintains the integrity of diagnostic results. Reuse is not recommended or supported by the manufacturer, as it could compromise sterility and accuracy.

  • What regulatory approval does the Biological Elution Solution hold, and how does it classify?

    The Biological Elution Solution holds FDA 510(k) clearance under the product code KSG, classified as a Class II medical device. It was granted clearance through the Hematology advisory committee, with a decision of substantial equivalence (SESE) to a predicate device. The solution is regulated under 21 CFR 864.9600, which governs media and reagents for in vitro diagnostic use.

  • Are there specific storage requirements mentioned for the Biological Elution Solution?

    While the device description does not specify exact storage conditions, it emphasizes compliance with standard laboratory practices for sterile reagents. This typically includes protection from light, contamination, and extreme temperatures, though exact parameters (e.g., refrigeration or room temperature) are not detailed. Always follow manufacturer guidelines or local regulatory standards for handling sterile diagnostic reagents.